# RMD Open

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/rmd-open/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 2056-5933 |
| ISSNs | 2056-5933 |
| OpenAlex ID | https://openalex.org/S2738706341 |
| Publisher | BMJ |

## Journal papers

Showing 12 of 13.

- [Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs](https://scholariq.org/papers/effects-of-physical-exercise-and-body-weight-on-disease-specific-outcomes-of/)
- [Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs](https://scholariq.org/papers/smoking-alcohol-consumption-and-disease-specific-outcomes-in-rheumatic-and/)
- [Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis](https://scholariq.org/papers/evaluation-of-hepatitis-b-virus-in-clinical-trials-of-baricitinib-in-rheumatoid/)
- [Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs](https://scholariq.org/papers/effects-of-diet-on-the-outcomes-of-rheumatic-and-musculoskeletal-diseases-rmds/)
- [Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension](https://scholariq.org/papers/burosumab-treatment-in-adults-with-x-linked-hypophosphataemia-96-week-patient/)
- [Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations](https://scholariq.org/papers/management-of-lupus-nephritis-a-systematic-literature-review-informing-the-2019/)
- [Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis](https://scholariq.org/papers/efficacy-and-safety-of-dose-escalation-of-tofacitinib-in-refractory-anti-mda5/)
- [Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome](https://scholariq.org/papers/systematic-literature-review-of-efficacy-effectiveness-and-safety-of-current/)
- [Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry](https://scholariq.org/papers/understanding-the-association-between-skin-involvement-and-joint-activity-in/)
- [Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry](https://scholariq.org/papers/still-s-disease-continuum-from-childhood-to-elderly-data-from-the-international/)
- [Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis](https://scholariq.org/papers/patterns-of-comorbidities-differentially-affect-long-term-functional-evolution/)
- [Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial](https://scholariq.org/papers/mental-health-fatigue-and-function-are-associated-with-increased-risk-of-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.